Literature DB >> 8902948

Regionally different elevation of intracellular free calcium in hippocampus of septic rat brain.

R Z Zhan1, N Fujiwara, K Shimoji.   

Abstract

The effect of sepsis on cellular calcium homeostasis in the central nervous system (CNS) was investigated using hippocampal slices of rats in which sepsis was induced by cecal ligation and puncture (CLP). Hippocampal slices were prepared from septic or sham-operated rats at 24 h after abdominal surgery. The basal intracellular calcium ([Ca2+]i) and its response to oxygen-glucose deprivation in hippocampal slices were measured for assessing cellular calcium homeostasis using fura-2 fluorescent imaging technique. The levels of [Ca2+]i were estimated by the fluorescence ratio (R340/380). Twenty-four hours after CLP, spontaneous movement was reduced and plasma lactate was increased in the septic rats in comparison with the sham-operated rats in which laparotomy was performed without CLP. Basal level of R340/380 in the CA4 ara (.72 +/- .07) was significantly higher (p < .001) in the septic group than that in the sham-operated group (.55 +/- (.06). The fluorescence ratio of septic vs. sham-operated in other hippocampal regions were .55 +/- .09 vs. .48 +/- .06 in CA1 (not significant) and .65 +/- .10 vs. .59 +/- .08 (not significant) in CA3, respectively. Increase in [Ca2+]i due to oxygen-glucose deprivation was significant in CA1 and CA3 of the septic group and in all hippocampal regions of sham-operated group. However, it was not significantly increased in CA4 of the septic group. These results suggest that regional deregulation of cellular calcium occurs in the CNS following CLP. Cellular calcium deregulation may be one of the pathogeneses occurred in clinically observed septic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902948     DOI: 10.1097/00024382-199610000-00012

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  9 in total

Review 1.  Neuro-oxidative-nitrosative stress in sepsis.

Authors:  Ronan M G Berg; Kirsten Møller; Damian M Bailey
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-13       Impact factor: 6.200

Review 2.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

Review 3.  Sepsis-associated encephalopathy: not just delirium.

Authors:  Fernando Godinho Zampieri; Marcelo Park; Fabio Santana Machado; Luciano Cesar Pontes Azevedo
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 4.  Science review: The brain in sepsis--culprit and victim.

Authors:  Tarek Sharshar; Nicholas S Hopkinson; David Orlikowski; Djillali Annane
Journal:  Crit Care       Date:  2004-09-08       Impact factor: 9.097

Review 5.  Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment.

Authors:  Divine C Nwafor; Allison L Brichacek; Afroz S Mohammad; Jessica Griffith; Brandon P Lucke-Wold; Stanley A Benkovic; Werner J Geldenhuys; Paul R Lockman; Candice M Brown
Journal:  J Cent Nerv Syst Dis       Date:  2019-04-09

Review 6.  Sepsis Associated Encephalopathy.

Authors:  Neera Chaudhry; Ashish Kumar Duggal
Journal:  Adv Med       Date:  2014-09-30

Review 7.  Immunosenescence in neurocritical care.

Authors:  Shigeaki Inoue; Masafumi Saito; Joji Kotani
Journal:  J Intensive Care       Date:  2018-10-12

Review 8.  Role of microRNAs As Biomarkers in Sepsis-Associated Encephalopathy.

Authors:  Rebeca Osca-Verdegal; Jesús Beltrán-García; Federico V Pallardó; José Luis García-Giménez
Journal:  Mol Neurobiol       Date:  2021-06-23       Impact factor: 5.682

9.  Disease Outcome and Brain Metabolomics of Cyclophilin-D Knockout Mice in Sepsis.

Authors:  Takayuki Kobayashi; Hiroyuki Uchino; Eskil Elmér; Yukihiko Ogihara; Hidetoshi Fujita; Shusuke Sekine; Yusuke Ishida; Iwao Saiki; Shoichiro Shibata; Aya Kawachi
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.